170 related articles for article (PubMed ID: 32893112)
1. Factors Influencing the False Positive Rate in CT Lung Cancer Screening.
Hammer MM; Byrne SC; Kong CY
Acad Radiol; 2022 Feb; 29 Suppl 2(Suppl 2):S18-S22. PubMed ID: 32893112
[TBL] [Abstract][Full Text] [Related]
2. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
3. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Lung-RADS category 4 lesions in a university lung cancer screening program.
Kocher Wulfeck M; Plesner S; Herndon JE; Christensen JD; Patz EF
Lung Cancer; 2023 Dec; 186():107420. PubMed ID: 37956610
[TBL] [Abstract][Full Text] [Related]
5. Community-based Lung Cancer Screening Results in Relation to Patient and Radiologist Characteristics: The PROSPR Consortium.
Burnett-Hartman AN; Carroll NM; Honda SA; Joyce C; Mitra N; Neslund-Dudas C; Olaiya O; Rendle KA; Schnall MD; Vachani A; Ritzwoller DP
Ann Am Thorac Soc; 2022 Mar; 19(3):433-441. PubMed ID: 34543590
[No Abstract] [Full Text] [Related]
6. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
Hammer MM; Hunsaker AR
AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
[No Abstract] [Full Text] [Related]
7. Delays in Recommended Follow-Up after Positive Findings in Lung Cancer Screening.
Ahmed A; Hippe DS; Snidarich M; Crothers K; Triplette M
Ann Am Thorac Soc; 2023 Aug; 20(8):1175-1181. PubMed ID: 36973008
[No Abstract] [Full Text] [Related]
8. Factors Associated With Lung Cancer Screening Adherence Among Patients With Negative Baseline CT Results in a Community Health Care Setting.
Bastani M; Patel D; Silvestri GA; Raoof S; Chusid J; Cohen SL
J Am Coll Radiol; 2022 Feb; 19(2 Pt A):232-239. PubMed ID: 34861204
[TBL] [Abstract][Full Text] [Related]
9. Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study.
Kim RY; Rendle KA; Mitra N; Saia CA; Neslund-Dudas C; Greenlee RT; Burnett-Hartman AN; Honda SA; Simoff MJ; Schapira MM; Croswell JM; Meza R; Ritzwoller DP; Vachani A
Ann Am Thorac Soc; 2022 Sep; 19(9):1561-1569. PubMed ID: 35167781
[No Abstract] [Full Text] [Related]
10. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
[TBL] [Abstract][Full Text] [Related]
11. Association between visual emphysema and lung nodules on low-dose CT scan in a Chinese Lung Cancer Screening Program (Nelcin-B3).
Yang X; Dorrius MD; Jiang W; Nie Z; Vliegenthart R; Groen HJM; Heuvelmans MA; Sidorenkov G; Vonder M; Ye Z; de Bock GH
Eur Radiol; 2022 Dec; 32(12):8162-8170. PubMed ID: 35678862
[TBL] [Abstract][Full Text] [Related]
12. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
[TBL] [Abstract][Full Text] [Related]
13. Variability in interpretation of low-dose chest CT using computerized assessment in a nationwide lung cancer screening program: comparison of prospective reading at individual institutions and retrospective central reading.
Hwang EJ; Goo JM; Kim HY; Yoon SH; Jin GY; Yi J; Kim Y
Eur Radiol; 2021 May; 31(5):2845-2855. PubMed ID: 33123794
[TBL] [Abstract][Full Text] [Related]
14. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.
Lin Y; Liang LJ; Ding R; Prosper AE; Aberle DR; Hsu W
JAMA Netw Open; 2023 May; 6(5):e2315250. PubMed ID: 37227725
[TBL] [Abstract][Full Text] [Related]
17. Interpreting Lung Cancer Screening CTs: Practical Approach to Lung Cancer Screening and Application of Lung-RADS.
Jhala K; Byrne SC; Hammer MM
Clin Chest Med; 2024 Jun; 45(2):279-293. PubMed ID: 38816088
[TBL] [Abstract][Full Text] [Related]
18. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR
AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453
[No Abstract] [Full Text] [Related]
19. Use of Diagnostic CT and Patient Retention in a Lung Cancer Screening Program.
Byrne SC; Hammer MM
J Am Coll Radiol; 2022 Jan; 19(1 Pt A):47-52. PubMed ID: 34752759
[TBL] [Abstract][Full Text] [Related]
20. Performance of ACR Lung-RADS in a clinical CT lung screening program.
McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]